Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

PHASE3CompletedINTERVENTIONAL

Enrollment

709

Participants

Timeline

Start Date

April 23, 2021

Primary Completion Date

June 21, 2022

Study Completion Date

January 13, 2023

Conditions

Primary HypercholesterolemiaMixed Hyperlipemia

Interventions

DRUG

SHR-1209

DRUG

SHR-1209 Placebo

Trial Locations (1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY